Tenaya Therapeutics Inc (TNYA)
4.56
-0.12
(-2.56%)
USD |
NASDAQ |
May 06, 16:00
4.54
-0.02
(-0.44%)
Pre-Market: 20:00
Tenaya Therapeutics Cash and Short Term Investments (Quarterly): 104.64M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 104.64M |
| September 30, 2023 | 121.75M |
| June 30, 2023 | 132.50M |
| March 31, 2023 | 147.81M |
| December 31, 2022 | 186.53M |
| September 30, 2022 | 149.45M |
| June 30, 2022 | 180.92M |
| Date | Value |
|---|---|
| March 31, 2022 | 210.45M |
| December 31, 2021 | 251.30M |
| September 30, 2021 | 280.46M |
| June 30, 2021 | 111.89M |
| March 31, 2021 | 128.44M |
| December 31, 2020 | 128.54M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
104.64M
Minimum
Dec 2023
280.46M
Maximum
Sep 2021
164.21M
Average
147.81M
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Adverum Biotechnologies Inc | 96.53M |
| Solid Biosciences Inc | 123.64M |
| Dyne Therapeutics Inc | 453.55M |
| Sana Biotechnology Inc | 205.20M |
| Prime Medicine Inc | 121.66M |